Simulations Plus (NASDAQ:SLP) Stock Rating Lowered by Wall Street Zen

Simulations Plus (NASDAQ:SLP) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Several other equities research analysts also recently weighed in on SLP. Zacks Research downgraded Simulations Plus from a “strong-buy” rating to a “hold” rating in a report on Monday, February 2nd. BTIG Research cut Simulations Plus from a “buy” rating to a “neutral” rating in a research note on Thursday, December 18th. TD Cowen reissued a “hold” rating on shares of Simulations Plus in a research report on Thursday, January 8th. Finally, Citigroup restated a “market perform” rating on shares of Simulations Plus in a research note on Tuesday, January 6th. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Simulations Plus has an average rating of “Hold” and a consensus target price of $25.00.

Simulations Plus Price Performance

NASDAQ:SLP opened at $11.99 on Friday. Simulations Plus has a 52 week low of $11.09 and a 52 week high of $36.45. The company has a fifty day simple moving average of $13.06 and a two-hundred day simple moving average of $16.06. The company has a market cap of $241.60 million, a price-to-earnings ratio of -3.75 and a beta of 1.19.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Thursday, January 8th. The technology company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.05). The company had revenue of $18.42 million during the quarter, compared to analyst estimates of $18.05 million. Simulations Plus had a negative net margin of 81.66% and a positive return on equity of 14.02%. During the same quarter in the previous year, the business posted $0.17 earnings per share. On average, analysts expect that Simulations Plus will post 1.09 EPS for the current year.

Hedge Funds Weigh In On Simulations Plus

Several hedge funds have recently made changes to their positions in the company. North Star Investment Management Corp. lifted its holdings in shares of Simulations Plus by 195.6% in the 3rd quarter. North Star Investment Management Corp. now owns 168,130 shares of the technology company’s stock valued at $2,534,000 after purchasing an additional 111,255 shares during the last quarter. Tributary Capital Management LLC grew its stake in Simulations Plus by 214.7% during the 3rd quarter. Tributary Capital Management LLC now owns 1,136,980 shares of the technology company’s stock worth $17,134,000 after buying an additional 775,704 shares during the last quarter. Royce & Associates LP grew its stake in Simulations Plus by 31.6% during the 3rd quarter. Royce & Associates LP now owns 348,758 shares of the technology company’s stock worth $5,256,000 after buying an additional 83,758 shares during the last quarter. Tudor Investment Corp ET AL acquired a new position in Simulations Plus during the third quarter worth approximately $1,810,000. Finally, Herald Investment Management Ltd acquired a new position in Simulations Plus during the third quarter worth approximately $3,016,000. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.